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Abstract
Purpose The aim of this retrospective analysis of spinal fu-
sion, was to document the clinical, functional, and radiologi-
cal outcomes with a local bone graft plus the highly
osteoconductive hydroxyapatite, bio-derived Orthoss®, with
or without bone marrow aspirate.
Methods Forty seven patients submitted to spinal posterolat-
eral fusion were operated for four major indications: scoliosis
in young patients (11), degenerative spine (18), lumbosacral
transitional anomalies in young adults (14), and spine trauma
(four). Sixteen patients had more than four levels fused. In
addition to spinal decompression and instrumented fusion,
autologous bone grafts from the excised lamina were aug-
mented with Orthoss® granules in a 1:1 ratio. In addition iliac
crest bone marrow aspirate was used in 70 % of the patients.
The results were assessed clinically in terms of pain, and re-
turn to school or professional activities were checked at three,
six, and 12 months following surgery with a mean follow-up
of 20 months. In scoliotic patients, correction of the major
angle was evaluated from one to four years after surgery.
Results Pain persistence was reported only in four cases, after
three months after surgery. A functional recovery was noted in
almost all patients groups within these three months.
Progressive bone formation with evidence of bone fusion
masses were already observed at six months. No fusion failure
was observed.
Conclusions Local bone enhanced by an osteoconductive
long-term stable scaffold, used with and without bone marrow
aspirate, led to successful fusion in all patients by six months
while functional recovery was reported already within three to
six months.
Keywords Bone graft substitute . Bonemarrow aspirate .
Lumbar degenerative spine . Orthoss® . Scoliosis . Spinal
posterolateral fusion
Introduction
Spinal arthrodesis is performed in several indications to relieve
pain and correct deformities. In lumbar spondylolisthesis, the
spine is stabilized to reduce pain and disability in patients with
chronic back pain. In young scoliotic patients, fusion is pro-
posed after conservative treatments to ensure the realignment
and stabilization of scoliotic deformities. After trauma, verte-
bral body stabilization often utilizes instrumented fusion.
Commonly, the fusion process is stimulated and sustained by
local delivery of biological ingredients. Typically, bone grafts,
bone debris, bone graft substitutes, and/or biological adjuncts,
help achieve bone fusion mass formation adjacent to the verte-
bral bodies, and instrumented fusion together with bonemasses
are known to provide durable stabilization. The induction of
such heterotopic osteosynthesis requires nevertheless a com-
plex balance of biological factors and operative technique to
achieve successful fusion [1].
Surgical techniques for spinal arthrodesis have evolved
from purely non instrumented procedures to wiring tech-
niques, polyaxial screws, locked plating, and rod technology
[2]. Even more, several spinal fusion procedures can be
combined to ensure an initial stability of deformed vertebral
structures. To aid these procedures, commercially available
bone grafts, bone graft extenders, and osteobiologics have
been developed with the goal of decreasing the surgical
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morbidity associated with harvest of autologous iliac crest
bone grafts (ICBG). Although ICBG still represents the gold
standard, postoperative pain affecting 16-40 % of patients
and major complications such as vascular injury, nerve inju-
ry, fracture or hernias are still reported in up to 8.6 % of
cases [3]. To avoid the grafting morbidity and potential com-
plications, percutaneous aspiration of bone marrow stem cells
from the iliac crest is a viable alternative. Specifically, a ten-
fold reduction in complications has been reported with the use
of this methodology over classical iliac crest bone graft har-
vesting in reconstructive surgery by Hernigou et al. [4].
Accordingly, bone marrow aspirate was used in our patients
to circumvent the need for an iliac crest bone graft, whenever
possible.
The present retrospective analysis reports outcomes from
the daily practice of single and multilevel spinal fusions. We
used the unique combination of local bone, with or without
bone marrow graft aspirate, or in a limited number of cases
ICBG, to provide osteogenic progenitors. In addition, a struc-
tural osteoconductive scaffold was used as a bone graft ex-
tender to support long term stability of newly formed bone.
The selection of the osteoconductive agent was based on its
physical architecture, chemical nature, and its stability over
time. Since the rate of resorption is a critical factor when
considering bone grafts as adjuncts to spine fusion, rapid re-
sorbing calcium sulfate, or even ß-TCP, were not considered
in our practice. Moreover, synthetic sintered hydroxyl-apatite
was not used due to its limited interconnected porosity. The
issue of early or rapid graft dissolution before sufficient
osteoconduction led us to consider the use of a highly
osteoconductive and interconnected porous bone substitute
of hydroxyapatite nature.
Orthoss® (Geistlich Pharma AG, Wolhusen, Switzerland)
is a bovine–derived bone substitute, which has the structure of
the native trabecular bone, with unique interconnected poros-
ity. It is a natural hydroxyapatite, with no residual protein or
other organic material, having a high spontaneous permeabil-
ity to cells and fluids, is rapidly surrounded by new bone
without foreign body reaction or encapsulation. Due to its
nature, it resorbs very slowly with time (over years) making
it valuable for spine surgery.
This material was able to enhance rapid and complete bone
ingrowth while remaining as a stable scaffold to maintain the
long term volume stability of the heterotopic bony fusion.
The present report on spinal fusion in various indications,
includes complex fusion procedures involving more than two
levels. We used the osteoconductive Orthoss® hydroxyapatite
together with local bone debris from the decortication of the
pedicles and vertebra, and additional bone marrow stem cells
from the bone marrow aspirate to support fusion.
Osteoinductive agents were not used due to safety concerns
particularly in a young patient population, and to the variabil-
ity of the BMP content of the different DBM preparations [2].
Material and methods
Forty seven consecutive patients submitted to spinal postero-
lateral fusion in the period 2010–2011 were operated for four
major indications: scoliosis in young patients (n=11), degen-
erative spine (n=18), lumbosacral transitional anomalies in
young adults (n=14), and spine trauma (n=4). The respective
indications include evolutive scoliosis despite physiotherapy
and continuous orthotic treatment, and persistent low back
pain with or without neurological compromise that failed to
respond to at least 6 months of conservative treatment for the
degenerative and transitional anomalies.
Demographic data concerning the four patient groups, the
duration of follow-up, and the number of fusion levels are
summarized in Table 1. A total of 16 patients had more than
four levels fused. As expected, the higher number of fusion
levels was observed in scoliotic patients, with more than four
levels involved in ten of these patients. In the other indica-
tions, the majority of patients had two disc fusion levels. Two
patients were lost to follow-up in the immediate post-
operative period, so the report concerns 45 patients with a
mean follow-up of 20 months (up to 48 months).
In patients with degenerative spine, or lumbosacral anom-
alies, posterior decompression was achieved through
laminectomies and facetectomies at each concerned level.
Instrumented fusion was realized using pedicle screws, rods,
and plates. Rods were angulated as necessary. Autologous
bone grafts from the excised lamina were used bilaterally,
augmented with Orthoss® granules of 2–4 mm (amount of
7 g mixed 1:1 with autologous local bone).
Patients with scoliosis were all treated with posterior cor-
rection using Tenor instrumentation after opening the facets,
decortication of the laminae, transverse, and spinous process.
Local bone chips from the decortications, augmented with
Orthoss® granules, were placed on the opened facets and
decorticated surfaces.
Spine trauma was treated with posterior reduction using
Tenor osteosynthesis screws and rods. The instrumented fu-
sion was completed in all cases with bone fusion using local
bone chips, mixed with Orthoss® granules.
Orthoss® is a commercially available bone substitute of
bovine origin, obtained by a validated processing method that
enables organic components to be removed, while maintain-
ing the porous trabecular structure of the native bone (Fig. 1).
The granules are rapidly invaded by the surrounding bone
cells and their hydroxyapatite nature is associated with a very
low resorption rate [5].
In addition to local bone available from decortication and
Orthoss® granules, iliac crest bone marrow aspirate collected
through percutaneous aspiration was used in 13/18 patients
treated for degenerative spine, ten/14 patients treated for lum-
bosacral transitional anomalies, in three/four patients with spine
trauma, and in seven/11 patients treated for scoliosis. In total, 33
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among 47 patients (70 %) were treated with bone marrow as-
pirate. Iliac crest bone grafts mixed with local bone and with
Orthoss® granules were used only in two patients with transi-
tional anomalies, in whom the iliac crest was exposed during
the procedure. Local bone and Orthoss®, without iliac crest
graft or iliac bone marrow aspirate was used in five/18 degen-
erative spine, one/four trauma patients, four/11 scoliotic pa-
tients, and two/14 in patients with transitional anomalies. The
decision to add bone marrow aspirate or not was based on the
amount and quality of local bone available.
Posterolateral fusion was associated with interbody fusion
using cages in eight patients (four in the degenerative spine
and four in the young adult spondylolisthesis patients).
External immobilization by orthosis was prescribed after
surgery in all patient groups for the duration of one to four
months. The patients were encouraged to stand up and walk
by the fifth postoperative day.
Outcomes were assessed clinically in terms of general condi-
tions, return to school or professional activities at three, six, and
12 months following surgery. Pain in the spine or legs was
graded by the surgeon at each post-operative visit. Radiologic
assessments were performed on anteroposterior and lateral ra-
diographs with the patient in neutral standing position. X-rays
were taken before surgery, during the first week after surgery
and at three, six, and 12months. In scoliotic patients, the param-
eters measured were the Cobb angles of the curves on the frontal
plane, thoracic kyphosis, and lumbar lordosis. Correction of the
major angle (with 100 % being the preoperative level), was
evaluated at one and four to six months, one year, two years,
and ≥three years, and at the final follow-up. Success of the
vertebral fusion was assessed by the clinical outcomes of
reduction/absence of pain and function recovery for degenera-
tive or transitional anomalies, as well as maintenance of the
correction in scoliotic patients, and radiologic assessment for
the fusion with no need for secondary surgery on the operated
levels. Complications were classified as wound complications
(infection, hemorrhage, and wound dehiscence), procedure-
related complications (nerve palsy/injury, need for subsequent
procedure and bone fracture, implant failure, implant fracture)
and non-union/delayed union in a separate group.
Results
Overall pain at the fusion site, and functional recovery (sport
and/or professional activities) were evaluated according to the
clinical reports of each patient. These parameters are summa-
rized in Fig. 2a and b. Pain was reported after three months
following surgery only in four cases. Except in four cases,
functional recovery was noted in all patients groups within
three to six months after surgery.








Mean age (years), male, female 64 (53–77), 1 m, 3f 62 (50–77), 4 m, 14f 36 (15–48), 4 m, 10f 18 (13–35), 1 m, 10f
Levels involved, (n) 1-2 (0) 1-2 (12) 1-2 (11) 1-2 (1)
3 (2) 3 (3) 2-3 (2) 3 (0)
≥4 (2) ≥4 (3) ≥4 (1) ≥4 (10)
Follow-up, (n) (Ø= 20 m (4–48)) 4-6 m (3) 4-6 m (4) 4-6 m (2) 4-6 m (2)
1y (1) 1y (4) 1y (4) 1y (4)
2y (0) 2y (4) 2y (5) 2y (4)
≥3y (0) ≥3y (6) ≥3y (2) ≥3y (0)
Ø= 7.5 m (4–12) Ø= 22 m (4–48) Ø= 13 m (4–36) Ø= 17 m (5–30)
Lost to follow-up 0 0 1 1
Revision surgery 0 1 1 0
Adverse event (AE) 0 2 1 0
Fig. 1 Scanning electron microcopy of Orthoss® bone graft substitute
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In the scoliosis group, ten patients could be followed reg-
ularly (one patient went to another hospital for personal con-
venience). Correction of the major angle at the final follow-up
assessment was of 58 % ± 17.9 % as compared to pre-
operative values. Post-operative radiographs showed progres-
sive bone formation with evidence of bone fusion masses
already observed at six months. No fusion failure was ob-
served. No infection was reported in this patient group.
No neurologic or intra-operative/post-operative systemic com-
plications were observed. Acute post-operative infection was re-
ported in two patients, one being associated with early screw
displacement. Reinstrumentation in a revision surgery was per-
formed in two cases, after six weeks and ten months of the initial
surgeries, respectively. Each adverse event is detailed below:
Infectious process starting at one month was treated with
Pyostacin, but fistulas exposing the osteosynthetic material
were observed at nine months in a degenerative spine surgery.
Since the bone fusion was solid, the material was removed and
not replaced.
Early displacement of the L4 screws after six weeks, in a
patient with an indication of lumbosacral transitional anomaly
with subsequent Staphylococcus Aureus contamination.
Antibiotic therapy was initiated, the osteosynthetic material,
was replaced including an additional fusion level (L3, local bone
graft augmented with Orthoss®). Stable fusion took place
thereafter.
One patient in the degenerative lesion group had two
additional surgeries. The first at ten months after the
initial procedure (arthrodesis L4-S1 plus intersomatic
cage L4-L5) for a radiating pain resistant to medication.
The material on the right side was removed, L5-S1
foraminotomy and L4-S1 arthrodesis were performed.
After two years, MRI confirmed the presence of addi-
tional discopathies superior to the arthrodesis at the L2-
L3 and L3-L4 levels without discal hernia. The
material was removed and replaced by an extended
osteosynthesis L3-S1 plus arthrectomy and posterolateral
fusion. The follow-up of 3.5 months was uneventful.
Fig. 2 a Evolution of the pain relief over time measured as pain at the fusion level in the four intervention groups. b Evolution of the functional recovery
(sport and/or professional activities) over time in the four intervention groups
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The radiological follow-up showed a progressive incorpo-
ration of the bone graft material into the fusionmass with time.
Incorporation and integration was noted in almost all radiolog-
ical reports at six months and thereafter. In all cases Orthoss®
was used and contributed to the fusion mass. The radiodensity
and the long term stability of the granules allow visualization at
least two to three years though their radiopacity progressively
decreases with time (Figs. 3, 4, and 5).
Discussion
Although the number of surgical options available to manage
degenerative spondylolisthesis has increased in the last decade,
decompression laminectomy with partial medial facetectomy
and instrumented fusion remains the standard [6]. According
to the Spine Patient Outcomes Research Trial (SPORT) sub-
group analysis, no clear advantage of one fusion technique over
any other has been observed [7]. However, the addition of
interbody fusion should be considered in patients who are at
high risk of non-union, local kyphosis, high grade slip, and/or
symptomatic instability with sagitally oriented facet joints [6].
In the present study, the eight patients who benefited from
additional interbody fusion in the degenerative spine group
(n=4) and in the transitional anomalies group (n=4), had
discal hernia recurrence, with evidence of disc degeneration.
The rationale was to include an anterior column support, an
indirect foraminal decompression, and a restoration of lordosis.
Variable fusion rates are reported in spine surgery depend-
ing on the surgical technique, the instrumentation used, single
versus multiple fusion levels, and method of fusion detection
[8]. The present clinical, functional, and radiological results
dealing with multilevel treatments, are in agreement with
published data in the corresponding indications, using various
sources of bone grafts or bone substitutes. In this report, the
combined use of local bone and an osteoconductive graft ex-
pander in all patients, was supplemented in 70 % with bone
marrow aspirate. This strategy allows:
At least a similar fusion rate as in previous series using only
local bone with a solid fusion achieved in 94.9 % for lumbar
spondylolisthesis patients as reported by Kho and Chen [9]. A
range of 65 to 95 % of successful fusion rates based on plain
radiographic imaging was reported [10]. The local available
bone chips are of limited volume and insufficient for multi-
level fusions. In addition, this local bone is largely cortical
with a reduced number of progenitor cells as compared to
spongious components. Because of this, there is a need for
additional supply of both graft expander and cellular/
biological adjuncts in larger or high risk surgeries.
A similar fusion rate as with ICG: Dimar et al. [11] found a
fusion rate of single-level instrumented posterolateral fusion
from 89 to 83 %. The overall fusion rate achieved was report-
ed at 75 % for ICBG and 65 % with local bone grafts [12];
however, when only multilevel fusions were performed, the
fusion rates for ICBG and local bone were 66 % and 20 %,
respectively. Historical data report fusion rates with the use of
iliac crest in PLF from 50 to 90 % [10]. In addition, for sco-
liotic patients the mean correction of the deformity was in the
range of published series using iliac crest graft, 57 %±14 %
for iliac crest graft group [13]. While patients in the age range
15–25 years tend to be in a time of life that favors good
healing, i.e., the scoliotic group, it could be speculated that
older patients with eventual comorbidities, osteoporosis, or
smokers, might not achieve the same results with a purely
osteoconductive bone graft substitute. In these conditions
the concomitant use of bone marrow aspirate is to be
Fig. 3 Radiological follow-up of
a 54 year old male patient treated
for degenerative spine disease; a
six days after surgery; b
four months after surgery; c
one year after surgery. Removal
of the fixation nine months
post-operative. Fusion achieved
and bone substitute material still
observed in the fusion mass
International Orthopaedics (SICOT) (2016) 40:1875–1882 1879
recommended. The use of bone marrow aspirate, which con-
tains osteoinductive and osteogenic substances was suggested
to compare favorably to iliac crest bone graft [4, 14]. This is
also confirmed by the present results in all indications studied.
The re-operation rate also compared favorably with a prob-
ability of repeat surgery of 6.3 % at two years in the meta-
analysis on the use of BMP in spinal fusions [15]. This num-
ber excluded device-related re-operations, which accounted in
the meta-analysis for 25 %.Wound complications observed in
our study are also in the range of reported values from 1.2 %
[16] to 6 % [17]. Procedure reported complications were re-
portedwith an incidence of 5%, implant related complications
with an incidence of 1.1 %, non-union/delayed union at 0.1 %
[17], and overall major medical complications were reported
in 3.1 % of patients [16].
Concerning the selection of the bone graft extenders func-
tioning as scaffolds on which fusion bone can be built, clinical
studies have demonstrated good outcomes when ceramics are
Fig. 5 Radiological follow-up of
a 63 year old male patient treated
for degenerative spine disease. a
Immediate post-operative; b, c
Bone substitute material still
observed in the fusion mass two
and three years after surgery
Fig. 4 Radiological follow-up of
a 20 year old female treated for
juvenile scoliosis T12 /L4 (lateral
a-d, anteroposterior f-g). a
six weeks after surgery; b
five months after surgery the
fusion mass is notable; c one year
after surgery fusion achieved and
bone substitute material still ob-
served in the fusion mass; d
two years after surgery bone sub-
stitute material still observed in
the fusion mass; e 6 weeks after
surgery; f 5 months after surgery
the fusion mass is notable; g 2
years after surgery bone substitute
material still observed in the fu-
sion mass
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used as a bone graft extender with fusion rates of 82 to 90 % in
posterolateral fusions, whereas for multiple-level fusions, the
fusion rates with calcium sulfate combined with laminectomy
was also of 82 % in the surgical management of scoliosis [8].
Nevertheless the rapid dissolution of calcium sulfate bone
substitutes is not appropriate for spinal fusion indications
where heterotopic bone has to develop to ensure a
sustained mechanical support. However, several randomized
studies established the potential of ß-TCP biphasic materials
to induce spinal fusion at the same rate as autologous bone
[13, 18]. The prospective randomized trial of 60 scoliotic
patients treated with instrumented lumbar spinal fusion with
either ICBG or coralline hydroxyapatite established a fusion
rate of 100 % in all groups at one year post-operatively
[19]. Scaffolds made of mixtures of HA and ß-TCP pro-
vide osteoconduction for bone production as well as long
term stability leading to successful incorporation of a bone
fusion mass. The stable HA portion of the graft resorbs
over years, improving the structural rigidity of the fusion
site while ß-TCP resorbs within weeks or months [13].
This is also in agreement with a retrospective cohort anal-
ysis of three different bone grafts used in instrumented
spinal fusion for adolescent idiopathic scoliosis, showing
that outcomes are not influenced by the type of bone graft
or substitute [20]. The overall fusion rate for all ceramic
products reviewed recently as bone graft extender in the
lumbar spine among 1332 patients was 86.4 % and specific
ceramic product did not significantly affect fusion rate, but
ceramics used in combination with local autograft resulted
in significantly higher fusion rates [21].
The results of the current study dealing with posterolateral
fusion in different indications show that even in extensive fusion
levels, excellent clinical, functional, and radiological outcomes
can be achieved, without iliac crest graft when the appropriate
therapeutic paradigm is used. Once the spinal segments to be
fused are stabilized by internal fixation devices, the bone fusion
can be achieved by the combination of a porous scaffold
allowing cell and vessel ingrowth with local bone and bone
marrow aspirate. The naturally-derived interconnected structure
of Orthoss® allows ingrowth of bone cells and progenitor cells,
together with endogenous factors enabling ectopic bone forma-
tion, in a posterolateral bone fusion mass. The use of Orthoss®,
as a highly porous and interconnected hydroxyapatite, with no
organic residues that may induce local inflammation and inhibit
bone ingrowth, in conjunction with bone marrow mesenchymal
stem cells and local autologous bone offers an alternative to
autologous bone graft using iliac crest. It is still considered that
no bone substitute is better than fresh autogenous bone grafting
with ceramics, in particular, being unable to fulfill all the roles of
autologous bone graft [13]. However the combination used in
this study, offers the advantage of suppressing the morbidity of
iliac crest bone graft while providing, withminimal invasiveness,
the biologic autologous material to enhance ectopic bone
formation and fusion, as well as a relative long term stability of
the HA scaffold. This has been achieved in the young scoliotic
patients group as well as in elderly patients with degenerative
vertebral lesions. Finally, the long duration of the resorption
process of Orthoss® also contributes to a long term stability
of the fusion, since it provides a continuous bone remodeling
support within the fusion mass. In contrary, rapidly resorba-
ble β-TCP, or even autografts are associated with initial
decrease of the bone graft volumes. Up to 26 % decrease
in graft volume of autografts used in instrumented lumbar
fusion has been reported in the first 12 post-op months [22].
Similar findings were reported by Kong et al. who showed
that in instrumented posterolateral fusion, radio density and
fusion rate changes, evoking an earlier resorption of local
bone than a mixture of local bone and ß-TCP [23].
Beyond successful fusion achieved by the combinations
described here, local graft and Orthoss® and/or bone marrow
aspirate, there is definitely an associated reduced operation
time, an unlimited product availability even in extensive fu-
sion levels, using a reliable methodology. Finally all morbid-
ities associated with iliac crest graft can be reduced, providing
a direct benefit for the patient.
The combination of graft materials used in our patients
aided fusion by acting via several of four major mecha-
nisms. Osteogenesis was promoted by local bone where
grafts contained the cells that form bone or its precursors.
Osteoinduction was stimulated through bone marrow aspi-
rate and local bone with agents that recruit/differentiate cells
to the fusion site, including non-bony sites. Osteoconduction
was supported with the Orthoss® scaffold, and osteopromotion
with agents provided by the marrow aspirate to enhance bone
healing. Local bone combined with an osteoconductive and
long term stable scaffold has been used in all cases reported
in this study, where bonemarrow aspirate was supplemented in
70 % of these patients, thus enabling stable fusions at
six months and functional recovery in three to six months,
whichever indication is considered.
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